ContraFect Corp(NASDAQ:CFRX) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during Pre-market on Aug 9, 2016. Earnings per share were $-0.35. Analysts had estimated an EPS of $-0.27.
In a different note, PiperJaffray said it Initiates Coverage on ContraFect Corp, according to a research note issued on Jul 28, 2016. The shares have been rated ‘Overweight’ by the firm. On Jul 22, 2016, Maxim Group said it Downgrades its rating on ContraFect Corp.
ContraFect Corp (CFRX) shares turned negative on Wednesdays trading session with the shares closing down -0.04 points or -1.75% at a volume of 13,708. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $2.27. The peak price level was also seen at $2.27 while the days lowest was $2.2101. Finally the shares closed at $2.24. The 52-week high of the shares is $5.8 while the 52-week low is $2.0968. According to the latest information available, the market cap of the company is $93 M.
Several Insider Transactions has been reported to the SEC. On Jul 27, 2016, Steven C Gilman (CEO) purchased 20,000 shares at $2.48 per share price.Also, On Nov 18, 2015, Daniel Couto (SVP Manufacturing & Facilities) sold 2,872 shares at $3.81 per share price.On Mar 3, 2015, Julia P Gregory (CEO) purchased 11,778 shares at $4.61 per share price, according to the Form-4 filing with the securities and exchange commission.